Fig. 2: Kaplan–Meier estimates survival curves for the high-risk and low-risk groups according to the nine-lncRNA signature. | Nature Communications

Fig. 2: Kaplan–Meier estimates survival curves for the high-risk and low-risk groups according to the nine-lncRNA signature.

From: A lncRNA signature associated with tumor immune heterogeneity predicts distant metastasis in locoregionally advanced nasopharyngeal carcinoma

Fig. 2: Kaplan–Meier estimates survival curves for the high-risk and low-risk groups according to the nine-lncRNA signature.

a–c Distant metastasis-free survival (a), disease-free survival (b), and overall survival (c) in the training cohort (n = 177). d–f Distant metastasis-free survival (d), disease-free survival (e), and overall survival (f) in the Guangzhou internal validation cohort (n = 177). g–i Distant metastasis-free survival (g), disease-free survival (h), and overall survival (i) in the Guilin external validation cohort (n = 150). The log-rank test was used to calculate P values (two-sided), and univariate Cox regression analyses were used to estimate the hazard ratios. HR hazard ratio, CI confidence interval. Source data are provided as a Source Data file.

Back to article page